Phenomenex President and CEO Fasha Mahjoor Named Finalist for Ernst & Young Entrepreneur of the Year 2010 Awards
Phenomenex announced that president and CEO Fasha Mahjoor has been selected as a finalist for Ernst & Young's Greater Los Angeles Entrepreneur of the Year 2010 award. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mahjoor was selected as a finalist from a large pool of nominees by a panel of eight independent judges, after many interviews and a detailed investigation of the company and the CEO's history and business performance.
Phenomenex CEO Fasha Mahjoor.
Phenomenex
"At Phenomenex, we are not only building a business, but a vibrant culture based on swift initiative, perseverance and responsibility to each other and to the community. This culture enables our remarkable team in 64 different countries to see and seize opportunities in good times and in adversity, through ear and well-defined strategies," said Mahjoor. "As they say, 'when the going gets tough, the tough get going,' which describes our culture very well - always aiming high and developing better technologies, technical support and sales and marketing strategies than our competitors."
The winner of the Entrepreneur of the Year 2010 Award will be announced on June 22, 2010 during a banquet held at the Beverly Hills Hilton Hotel.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay (MSIA) Workflow Development
Farfield Scientific: Five New Patents Granted, Building on a Portfolio of Over 50 Applications Pending
North American Scientific Completes Sale of Non-Therapeutic Product Line
Beckman Coulter Announces the Creation of Beckman Coulter Genomics - New Company Offers Comprehensive Genomic Services
Bruker to acquire the NanoString business in an asset deal
Ultrasonic Scientific Expands its Operations with the Appointments of Italien and Japanese Distributors
DNTOX receives €1.4 million seed funding for non-animal testing of chemicals - The new capital will be used to set up the test laboratories in Düsseldorf, aim for GLP accreditation and launch the test battery on the market
Oxford Instruments announces major technology licensing deal with GE Healthcare - Result will be powerful new tool for in vitro molecular analysis
